Acceleron Pharma Inc Marge bénéficiaire
Quel est le Marge bénéficiaire de Acceleron Pharma Inc?
Le Marge bénéficiaire de Acceleron Pharma Inc est -226.01%
Quelle est la définition de Marge bénéficiaire?
La marge bénéficiaire est une mesure de la rentabilité et est calculée en calculant le bénéfice net en tant que pourcentage du chiffre d'affaires.
Profit margin is calculated with the selling price (or revenue) taken as base times 100. It is the percentage of selling price that is turned into profit. Profit percentages are calculated to find the ratio of profit to cost of an investment. Profit margin is an indicator of a company's pricing strategies and how well it controls costs. Differences in competitive strategy and product mix cause the profit margin to vary among different companies. The profit margin is used mostly for internal comparisons. It is difficult to accurately compare the net profit ratio for different entities. Individual businesses' operating and financing arrangements vary so much that different entities are bound to have different levels of expenditure, so that comparison of one with another can have little meaning. A low profit margin indicates a low margin of safety: higher risk that a decline in sales will erase profits and result in a net loss, or a negative margin.
Marge bénéficiaire des entreprises dans Health Care secteur sur NASDAQ par rapport à Acceleron Pharma Inc
Que fait Acceleron Pharma Inc?
Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron's leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair.
Entreprises avec marge bénéficiaire similaire à Acceleron Pharma Inc
- Red Metal a Marge bénéficiaire de -226.64%
- Scancell Plc a Marge bénéficiaire de -226.57%
- Element ASA a Marge bénéficiaire de -226.43%
- Jaypee Infratech a Marge bénéficiaire de -226.42%
- Ironwood Pharmaceuticals Inc a Marge bénéficiaire de -226.37%
- Fourth Wave a Marge bénéficiaire de -226.25%
- Acceleron Pharma Inc a Marge bénéficiaire de -226.01%
- UrtheCast a Marge bénéficiaire de -225.45%
- New Standard a Marge bénéficiaire de -225.33%
- Lekoil a Marge bénéficiaire de -225.30%
- Auto Italia a Marge bénéficiaire de -225.30%
- World High Life Plc a Marge bénéficiaire de -225.25%
- Archer Materials a Marge bénéficiaire de -224.30%